Justices Give Boost to Securities Fraud Plaintiffs in Merck Ruling

, The National Law Journal

   | 0 Comments

In a rare boost for securities fraud class actions, the Supreme Court on Tuesday closed off a statute of limitations defense for Merck & Co. in its battle against Vioxx-related shareholder suits. Plaintiffs and shareholder groups applauded the decision for sweeping away a morass of conflicting lower-court decisions on statute of limitations rules and finding that the clock should start ticking only after plaintiffs discover the facts of the fraud violation -- including whether the company intended to defraud investors.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202453284354

Thank you!

This article's comments will be reviewed.